Abu Dhabi’s G42 Healthcare has signed a preliminary agreement with Israel’s NanoScent

“'The non-invasiveness and the rapidity of results give Scent Check the potential to transform the diagnostics industry globally,' WAM said. The device captures exhaled air, and analyses the 'volatile organic compounds' present using machine learning, the statement said."